Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study
Clinical trial NCT07018401 · COMPLETED
Trial details
- NCT number
- NCT07018401
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-04-08
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.